Related Experiment Video
Updated: Dec 4, 2025
An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
Current progress with mammalian models of mitochondrial DNA disease
James Bruce Stewart1,2,3
1Max Planck Institute for Biology of Ageing, Cologne, Germany.
Abstract:
Mitochondrial disorders make up a large class of heritable diseases that cause a broad array of different human pathologies. They can affect many different organ systems, or display very specific tissue presentation, and can lead to illness either in childhood or later in life. While the over 1200 genes encoded in the nuclear DNA play an important role in human mitochondrial disease, it has been known for over 30 years that mutations of the mitochondria's own small, multicopy DNA chromosome (mtDNA) can lead to heritable human diseases. Unfortunately, animal mtDNA has resisted transgenic and directed genome editing technologies until quite recently. As such, animal models to aid in our understanding of these diseases, and to explore preclinical therapeutic research have been quite rare. This review will discuss the unusual properties of animal mitochondria that have hindered the generation of animal models. It will also discuss the existing mammalian models of human mtDNA disease, describe the methods employed in their generation, and will discuss recent advances in the targeting of DNA-manipulating enzymes to the mitochondria and how these may be employed to generate new models.
Insights
Creating animal models for mitochondrial DNA (mtDNA) diseases has been challenging due to technical hurdles. Recent advances in mitochondrial targeting may enable new models for studying these heritable conditions.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Background:
- Mitochondrial disorders are heritable diseases caused by mutations in nuclear DNA or mitochondrial DNA (mtDNA).
- mtDNA mutations are a significant cause of human mitochondrial diseases, affecting various organ systems.
- Generating animal models for mtDNA diseases has been historically difficult due to technical limitations.
Purpose of the Study:
- To review the challenges in creating animal models for mitochondrial DNA (mtDNA) diseases.
- To discuss existing mammalian models of human mtDNA disease and their generation methods.
- To explore recent advances in mitochondrial targeting technologies for developing new disease models.
Main Methods:
- Review of existing literature on mitochondrial disorders and animal models.
- Analysis of technical challenges in animal mtDNA manipulation.
- Discussion of recent advancements in targeted DNA-modifying enzymes for mitochondria.
Main Results:
- Animal mtDNA has historically resisted transgenic and genome editing technologies, limiting model creation.
- Existing mammalian models for human mtDNA disease are rare and generated through specific methods.
- Recent advances in targeting DNA-manipulating enzymes to mitochondria show promise for novel model generation.
Conclusions:
- Overcoming technical barriers in animal mtDNA manipulation is crucial for advancing research.
- New therapeutic strategies and preclinical research can benefit from improved animal models of mtDNA disease.
- Targeting DNA-modifying enzymes to mitochondria represents a promising avenue for generating novel disease models.
